Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Claire A Quiner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Solutions, RTI International, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: One Health, Public Health, Communicable Diseases, Epidemiological Monitoring. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Globalization, over the past century, has extended the geographic range of infectious pathogens. Where physical distance previously protected populations from pathogens circulating in distant places, factors such as population growth, urbanization, modern transportation networks, and climate change have increased local expansion and amplification and cross-boundary spread of pathogens into naïve locations. Despite this possibility, a lack of historical endemicity of a pathogen in a region can delay its detection due to unfamiliarity with the symptomatology or limited diagnostics.
Methods
We developed the One Health transmission potential framework for assessing a pathogen, using a history-agnostic approach, that incorporates—but does not rely solely on—prior detection of it, to determine its transmission potential within a region. This framework was applied to 71 pathogens for Nigeria, and the results were used to inform the selection of pathogens for the Surveillance of Acute Febrile Illness Aetiologies in Nigeria (SAFIAN) study.
Results
The assessment identified transmission potential for 16 pathogens for which no previous detection in humans in Nigeria was found. The SAFIAN study screened 1200 patients for 25 pathogens with transmission potential in Nigeria. Outcomes included the detection of 11 pathogens, with no previous molecular detection in humans in Nigeria, and 9 pathogens ranked as high risk for causing Public Health Emergencies of International concern.
Conclusions
These results indicate the utility of the One Health transmission potential framework and its role in global health security. To prepare for surreptitious circulation of a pathogen, a history-agnostic approach is needed, whereby evidence, beyond previous detection in a region, is used to determine pathogens' potentials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Solutions, RTI International, Durham, North Carolina, USA.
- Internal Medicine, University of Abuja Teaching Hospital, Abuja, Nigeria.
- APIN Public Health Initiative, Abuja, Nigeria.
- Irrua Specialist Teaching Hospital, Edo, Nigeria.
ORCID-Profile: Claire A Quiner, Lauren P Courtney, Jean Kim, Vivian Kwaghe, Jay Osi Samuels, Cyril Erameh, Emmanuel A Oga
Zitieren
APA
Quiner, C. A., Courtney, L. P., Kim, J., Kwaghe, V., Samuels, J. O., Erameh, C., Ephraim, A. Z., & Oga, E. A. (2025). Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf487
Vancouver
Quiner CA, Courtney LP, Kim J, Kwaghe V, Samuels JO, Erameh C, et al. Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf487
BibTeX
@article{Quiner2025,
author = {Quiner, Claire A and Courtney, Lauren P and Kim, Jean and Kwaghe, Vivian and Samuels, Jay Osi and Erameh, Cyril and Ephraim, Adamu Zigwai and Oga, Emmanuel A},
title = {Design and Implementation of a One Health Framework for Evaluating the Transmission Potential of Pathogens of Public Health Interest for Surveillance Studies},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf487}
}
EUVIMED